Forebyggelse af herpes zoster med vaccination
Research output: Contribution to journal › Journal article › Research › peer-review
Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects.
Translated title of the contribution | [Prevention of herpes zoster by vaccination] |
---|---|
Original language | Danish |
Journal | Ugeskrift for Laeger |
Volume | 173 |
Issue number | 2 |
Pages (from-to) | 110-4 |
Number of pages | 5 |
ISSN | 0041-5782 |
Publication status | Published - 10 Jan 2011 |
ID: 40154850